Spray-Dried Drug-Loaded Human Serum Albumin Nanocarriers for Advanced Aerosol Delivery
The development of a formulation platform of engineered human serum albumin (HSA)-based nanoparticles as advanced carriers for aerosol drug delivery
Details
- Funder: Vinnova
Description
Research scientist: Lin Liu, PhD student
Principal Investigator: Professor Albert Mihranyan, Department of Pharmaceutical Biosciences, Uppsala University
Aim. To develop a formulation platform of engineered human serum albumin (HSA)-based nanoparticles as advanced carriers for aerosol drug delivery, leveraging albumin's natural transport capabilities for a variety of therapeutic indications.